Capitalizing on the flexibility of tiny cells inside the body's smallest blood vessels may be a powerful spinal cord repair ...

Capitalizing on the flexibility of tiny cells inside the body's smallest blood vessels may be a powerful spinal cord repair strategy, new research suggests. Capitalizing on the flexibility of tiny ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, and the Christopher & Dana Reeve ...

Sponsored Level 1 ADR program facilitates trading by US investors following recent FDA clearance and commercial launch BNY ...

Imaging shows regeneration of sensory axons four weeks after a spinal cord injury in an adult mouse injected with PDGF-BB at the lesion site. COLUMBUS, Ohio – Capitalizing on the flexibility of ...

NurExone's ExoTherapy platform enables precise, minimally-invasive delivery of therapies to injured tissues using exosomes as an advanced delivery system. With a growing body of preclinical data and ...